Out of a group of 3,817 people who completed a 12-week prescription of reSET-O, 643 were prescribed a refill of another 12 weeks. For those who completed a total of 24 weeks of treatment, abstinence ...
reSET-O is not intended to be used as a stand-alone therapy for Opioid Use Disorder (OUD). reSET-O does not replace care by a licensed medical practitioner and is not intended to reduce the frequency ...
Pear Therapeutics announced Wednesday that Massachusetts’ Medicaid program plans to cover its digital prescription therapeutics for treating substance and opioid use disorders, reSET and reSET-O. The ...
BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), today ...
PursueCare, a leader in virtual addiction treatment, today announced the rollout of RESET ® and RESET-O ® , the only FDA-authorized prescription digital therapeutics (PDTs) for substance use disorder ...
BOSTON--(BUSINESS WIRE)-- Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced ...
BOSTON & EAGAN, Minn.--(BUSINESS WIRE)--More than 20 million Americans struggle with drug addiction while only 10-20% receive treatment. 1 Prime Therapeutics LLC (“Prime”) and Pear Therapeutics, Inc. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results